nodes	percent_of_prediction	percent_of_DWPC	metapath
Rescinnamine—SLC18A2—uterine cervix—fallopian tube cancer	0.155	0.155	CbGeAlD
Rescinnamine—SLC18A2—endometrium—fallopian tube cancer	0.14	0.14	CbGeAlD
Rescinnamine—SLC18A2—uterus—fallopian tube cancer	0.129	0.129	CbGeAlD
Rescinnamine—SLC18A2—female reproductive system—fallopian tube cancer	0.116	0.116	CbGeAlD
Rescinnamine—ACE—epithelium—fallopian tube cancer	0.107	0.107	CbGeAlD
Rescinnamine—SLC18A2—vagina—fallopian tube cancer	0.105	0.105	CbGeAlD
Rescinnamine—ACE—endometrium—fallopian tube cancer	0.0958	0.0958	CbGeAlD
Rescinnamine—ACE—female reproductive system—fallopian tube cancer	0.0793	0.0793	CbGeAlD
Rescinnamine—ACE—female gonad—fallopian tube cancer	0.0722	0.0722	CbGeAlD
